Browse by Authors and Editors

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 2.

Article

Ghaneh, Paula and Hanson, Robert and Titman, Andrew and Lancaster, Gill and Plumpton, Catrin and Lloyd-Williams, Huw and Tien Yeo, Seow and Edwards, Rhiannon T. and Johnson, Colin and Hilal, Mohammed Abul. and Higginson, Antony P. and Armstrong, Tom and Smith, Andrew and Scarsbrook, Andrew and McKay, Colin and Carter, Ross and Sutcliffe, Robert P. and Bramhall, Simon and Kocher, Hemant M. and Cunningham, David and Pereira, Stephen P. and Davidson, Brian and Chang, David and Khan, Saboor and Zealley, Ian and Sarker, Debashis and Al Sarireh, Bilal and Charnley, Richard and Lobo, Dileep N. and Nicolson, Marianne and Halloran, Christopher and Raraty, Michael and Sutton, Robert and Vinjamuri, Sobhan and Evans, Jonathan and Campbell, Fiona and Deeks, Jon and Sanghera, Bal and Wong, Wai-Lup and Neoptolemos, John P. (2018) PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. Health Technology Assessment, 22 (7). ISSN 1366-5278

Middleton, Gary and Silcocks, Paul and Cox, Trevor and Valle, Juan and Wadsley, Jonathan and Propper, David and Coxon, Fareeda and Ross, Paul and Srinivasan, Madhusudan and Roques, Tom and Cunningham, David and Falk, Stephen and Wadd, Nick and Harrison, Mark and Corrie, Pippa and Iveson, Tim and Robinson, Angus and McAdam, Karen and Eatock, Martin and Evans, Jeff and Archer, Caroline and Hickish, Tamas and Garcia-Alonso, Angel and Nicolson, Marianne and Steward, William and Anthoney, D. Alan and Greenhalf, William and Shaw, Victoria E. and Costello, Eithne and Naisbitt, Dean and Rawcliffe, Charlotte and Nanson, Gemma and Neoptolemos, John P. (2014) Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial. Lancet Oncology, 15 (8). pp. 829-840. ISSN 1474-5488

This list was generated on Fri Jul 20 10:32:22 2018 UTC.